You are here: Industry Insights > Mateon

News List

Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform expresspharma
March 08, 2021
Interim data from clinical trials show PulmoHeal’s efficacy in improving recovery of mild and moderate Covid-19 patients.
Windlas Biotech, Mateon Therapeutics partner to launch combined lung therapy and AI telemedicine solution expresspharma
February 23, 2021
The solution consists of three components: the drug PulmoHeal, an AI lung health assessment tool called ArtiHealthand, a post-marketing survey platform.
Mateon launches antiviral programme focused on Covid-19 pharmaceutical-technology
March 04, 2020
Mateon Therapeutics has launched an antiviral response programme that will initially focus on Covid-19 disease caused by the novel coronavirus.
Mateon and PointR to merge into AI-driven oncology firm pharmaceutical-technology
August 21, 2019
Immuno-oncology company Mateon Therapeutics has signed a definitive agreement to merge with PointR Data, a computer and artificial intelligence (AI) company, to form an AI-driven firm focused on cancer treatment.